| Name | 2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide |
|---|---|
| Synonyms |
2-Hydroxy-N-(3-(trifluoromethyl)phenyl)benzamide
Salfluverine 3'-(trifluormethyl)salicylanilide m-Salicylaminotrifluoromethylbenzene 3'-(Trifluormethyl)salicylanilid Salfluverinum [INN-Latin] 2-(3-Trifluormethylphenylcarbamoyl)phenol Salfluverina [INN-Spanish] 2-Hydroxy-3'-(trifluormethyl)benzanilid N-(3-trifluoromethylphenyl)-2-hydroxybenzamide EINECS 209-601-4 |
| Density | 1.404g/cm3 |
|---|---|
| Boiling Point | 298.8ºC at 760mmHg |
| Molecular Formula | C14H10F3NO2 |
| Molecular Weight | 281.23000 |
| Flash Point | 134.5ºC |
| Exact Mass | 281.06600 |
| PSA | 49.33000 |
| LogP | 3.73630 |
| Index of Refraction | 1.591 |
|
~%
587-49-5 |
| Literature: NATIONAL DEFENSE MEDICAL CENTER; HUANG, HSU-SHAN; LAI, JENN-HAUNG; HO, LING-JUN; LIU, FENG-CHENG Patent: US2013/72720 A1, 2013 ; Location in patent: Paragraph 0029; 0030 ; |
|
~%
587-49-5 |
| Literature: Romark Laboratories, L.C. Patent: US2012/108592 A1, 2012 ; |